9 December 2021
SyVento and OncoArendi have signed a joint development collaboration and exclusive global licensing agreement for the use of the nanoliposomal formulation of the arginase inhibitor OATD-02.
Details in following press release.
27 September 2023
SyVento BioTech Participates in the Polish-British Future of Healthcare EventLONDON, September 26, 2023 – The Polish-British Future of Healthcare Event, focusing on advancements in MedTech, BioTech, and scientific research, will...
11 September 2023
SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local RootsSyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots In a strategic move that aims to consolidate our position...
31 August 2023
SyVento BioTech at the Forefront of RNA Therapeutics and Vaccines ConferenceIn an era where breakthroughs in RNA therapeutics are revolutionizing medicine, SyVento BioTech’s expertise in Lipid Nanoparticle (LNP) formulations stands out...
24 August 2023
SyVento BioTech at PHASE 2023 ConferenceSyVento BioTech at PHASE 2023 Conference The PHASE 2023 Conference stood as one of the most crucial discussions in the Polish...
1 August 2023
Reflecting on Our Participation in the 13th International Scientific Conference on AlkaptonuriaWe are proud to look back on our participation in the recently concluded 13th International Scientific Conference on Alkaptonuria (AKU) that...
6 June 2023
Aktualizacja Siedziby SyVento Sp. z o.o. / Change of Registered Office of SyVento sp. z o.o.Jest nam niezmiernie miło poinformować, że SyVento Sp. z o.o. z dniem 5 czerwca 2023 roku oficjalnie przenosi swoją siedzibę. Nowy adres wpisany...
6 June 2023
SyVento BioTech Attends BIO International Convention 2023SyVento BioTech Attends BIO International Convention 2023 SyVento BioTech is currently participating in the BIO International Convention 2023. The organization’s representatives...
13 March 2023
RNA Leaders Europe Congress – Meet us at stand 16Tomasz Piec, President of Supervisory Board, Dominik Lipka, PhD Eng., Director of Research and Development, Board Member, and Oskar Szelest, PhD,...
29 April 2022
Let’s meet at Vitafoods 2022The countdown to the biggest event in the dietary supplement and functional food industry, Vitafoods Europe 2022, has begun. We have...